Zhengye Biotechnology Holding Limited Additional Paid in Capital, Common Stock
Zhengye Biotechnology Holding Limited (ZYBT) had Additional Paid in Capital, Common Stock of CNY 240.75 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-04-28
- 2025-12-31: Additional Paid in Capital, Common Stock 240.75M CNY.
- 2025-06-30: Additional Paid in Capital, Common Stock 240.75M CNY.
- 2024-12-31: Additional Paid in Capital, Common Stock 203.15M CNY.
- 2023-12-31: Additional Paid in Capital, Common Stock 203.15M CNY.
CNY
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | 240.75M CNY 20-F · filed 2026-04-28 |
| 2025-06-30 | 240.75M CNY 6-K · filed 2025-12-12 |
| 2024-12-31 | 203.15M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 203.15M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | $34.43M 20-F · filed 2026-04-28 |
| 2025-06-30 | $33.61M 6-K · filed 2025-12-12 |
| 2024-12-31 | $27.83M 20-F · filed 2025-07-03 |